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Understanding the role of horizontal gene transfer (HGT) in adaptation is a key challenge in evolutionary biology. In microbes,
an important mechanism of HGT is prophage acquisition (phage genomes integrated into bacterial chromosomes). Prophages
can influence bacterial fitness via the transfer of beneficial genes (including antibiotic-resistance genes, ARGs), protection from
superinfecting phages, or switching to a lytic lifecycle that releases free phages infectious to competitors. We expect these effects
to depend on environmental conditions because of, for example, environment-dependent induction of the lytic lifecycle. However,
it remains unclear how costs/benefits of prophages vary across environments. Here, studying prophages with/without ARGs in
Escherichia coli, we disentangled the effects of prophages alone and adaptive genes they carry. In competition with prophage-free
strains, benefits from prophages and ARGs peaked in different environments. Prophages were most beneficial when induction of
the lytic lifecyclewas common,whereas ARGsweremore beneficial upon antibiotic exposure andwith reduced prophage induction.
Acquisition of prophage-encoded ARGs by competing strains was most common when prophage induction, and therefore free
phages, were common. Thus, selection on prophages and adaptive genes they carry varies independently across environments,
which is important for predicting the spread of mobile/integrating genetic elements and their role in evolution.
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A major challenge in evolutionary biology is to understand the
role of horizontal gene transfer (HGT) in adaptation (Boto 2010).
This question is relevant for different types of organisms, includ-
ing prokaryotes and eukaryotes (Keeling and Palmer 2008), and
answering it requires that we understand how natural selection
acts on horizontally acquired genetic variation across different
environmental conditions. In bacteria, infectious viruses (phages)
are key agents of horizontal gene transfer (Touchon et al. 2017).
Some temperate phages exist exclusively episomally, whereas
others can integrate into bacterial chromosomes as prophages
and modify the bacterial phenotype (lysogenic conversion). This
may be beneficial to bacteria, depending on environmental con-
ditions (Waldor and Mekalanos 1996). However, some environ-
mental conditions lead to prophage induction (switching back to
the lytic cycle), killing the host cell, and releasing free phages.
Our understanding of when prophages will be costly/beneficial
to their bacterial hosts, and how these costs/benefits vary across
environmental conditions, remains limited (Touchon et al. 2017).
A second important reason to investigate selection on
prophages is they can transfer antibiotic resistance genes (ARGs).
This may happen via generalized or specialized transduction
(Blahova et al. 1999; Gabashvili et al. 2020), or by lysogenic con-
version, when ARGs are directly encoded on the phage genome
(Brenciani et al. 2010; Calero-Caceres et al. 2019). Whether or
not lysogenic conversion by means of ARG-encoding prophages
is an important driver of antibiotic resistance in nature is unclear.
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Although a recent viral metagenome (virome) analysis suggests
ARGs can be encoded on prophages (Moon et al. 2020), an-
other study suggested ARGs on prophages are less common than
previously thought, and showed experimentally that predicted
phage-encoded ARGs often failed to confer resistance (Enault
et al. 2017). Thus, quantifying the net fitness effects of prophages
with/without ARGs for bacteria across different environments
would improve both our basic understanding of the role of phage-
encoded DNA in evolution, and their potential contribution to the
spread of antibiotic resistance.
We hypothesize that the net fitness effects of both prophages
and adaptive genes they encode (here, ARGs) vary strongly de-
pending on environmental conditions. The benefit of carrying a
prophage-encoded ARG relative to costs of expressing it will be
higher in the presence of the selecting antibiotic, whereas in the
absence of the antibiotic, expression of the ARG may have a net
negative effect on bacterial fitness (a “cost of resistance”; Ander-
sson and Levin 1999). In some conditions, we expect such costs
to be compounded by prophages switching back to the lytic cy-
cle and killing the host (Casjens 2003; Paul 2008). This switch
from the lysogenic to the lytic cycle can happen spontaneously or
in response to environmental conditions, such as sub-inhibitory
antibiotic concentrations that trigger the bacterial SOS response
(Otsuji et al. 1959). Although lysis is detrimental for individ-
ual cells, the prophage-carrying population might in fact bene-
fit from the release of free phages, because they may infect and
kill competing cells that are susceptible to the released phages in
the same microbial community (Brown et al. 2006; Selva et al.
2009; Li et al. 2017). Whether a condition that induces the lytic
cycle is costly or beneficial for the host population is predicted
to depend on the balance between the costs of lysis within the
prophage-carrying population and the benefit that comes from
lysing susceptible competitors (Touchon et al. 2017). The ulti-
mate impact of prophages on their host’s fitness is complicated
further by the possibility that any free phages released via ly-
sis can potentially transfer ARGs to competing phage-susceptible
cells, further modulating competition between bacterial popula-
tions. Consequently, we expect the fitness of lysogens relative to
prophage-free strains to vary depending on antibiotic concentra-
tion and other environmental factors influencing prophage induc-
tion and lysogeny.
Fitness costs and benefits associated with prophages and
prophages that encode adaptive genes, such as ARGs remain in-
completely understood. This might be due, among other reasons,
to the difficulty of directly comparing prophage-free bacteria
with equivalent strains carrying prophages, both with and with-
out ARGs. Consequently, the following questions remain unan-
swered: (1) How does the net fitness effect of prophage carriage
vary across different antibiotic concentrations? (2) Are these ef-
fects specific to prophages that encode ARGs? (3) Are prophages
more beneficial in environmental conditions where lysis is more
frequent? (4) In which environmental conditions is the acqui-
sition of ARG-carrying prophages by susceptible strains most
likely? To answer these questions, we determined fitness costs
and benefits associated with ARGs encoded on naturally occur-
ring prophages of Escherichia coli. To test whether our results
are repeatable across different genotypes and resistance genes,
we used three common resistance genes encoded on four differ-
ent lambdoid phages. We used strains carrying these prophages,
with and without ARGs that we inserted into the prophages, in
various combinations (12 different lysogens). We competed each
lysogen against an antibiotic- and phage-susceptible strain (more
than 600 competitions in total) in multiple environmental con-
ditions (presence and absence of selective antibiotics at various
concentrations, and of a compound that induces the lytic cycle of
the prophage). This allowed us to differentiate between the effects
of prophages alone and prophages carrying ARGs on their bacte-
rial host’s fitness, and to do so across antibiotic concentrations
and conditions associated with increased lysis and free phage
production. We found that the fitness benefits from prophages
and prophage-encoded ARGs peaked in different environmental
conditions, suggesting that in some conditions prophages may in-
crease in frequency because of beneficial genes they carry, and in
others because of the benefits of prophage carriage itself, such as
lysis of susceptible competitors.
Material and Methods
ORGANISMS
We used E. coli K-12 MG1655 (hereafter wild-type, WT), which
has originally been cured of active prophages (Hayashi et al.
2006), and 12 different lysogens constructed from this strain
(Table 1). Specifically, we used four different prophages,
lambda+ (originally obtained as strain JL573 from J.W. Little,
University of Arizona), HK022, Phi80 (both originally obtained
fromM.E. Gottesman, Columbia University), and mEp234 (orig-
inally obtained from I.-N. Wang, SUNY Albany). The prophage
in each lysogen encoded either no antibiotic resistance gene
(ARG) or one of three different ARGs conferring resistance to
ampicillin (amp), kanamycin (kan), or chloramphenicol (cm).
To be able to compare different ARGs within the same phage
type and vice versa, phages carrying an ARG were constructed
using the first step (exchange of a gene with a resistance cassette)
of a λ Red-promoted gene replacement (Datsenko and Wanner
2000). Resistance cassettes were amplified from plasmids pKD3
(cat, chloramphenicol resistance), pKD4 (neo, kanamycin re-
sistance), and pGEM®-T Easy (bla, ampicillin resistance) with
primers that carry 5’ homology extensions (Table S1). Primers
were designed to omit the FRT-sites on pKD3 and pKD4.
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Table 1. Bacterial strains. TheWild Type (WT) is E. coli K-12MG1655. All other strains are lysogens constructed from this strain. Antibiotic
resistance phenotype abbreviations: amp - ampicillin, cm - Chloramphenicol, kan - kanamycin. Resistance gene abbreviations: bla - beta-
lactamase, cat -chloramphenicol acetyltransferase, neo - aminoglycoside phosphotransferase from Tn5.
Strain Prophage Antibiotic resistance phenotype
(resistance gene)
Gene deleted to insert resistance
marker
WT none none none
P1 lambda+ none none
P4 HK022 none none
P7 Phi80 none none
P19 mEp234 none none
140 lambda+ kan (neo) bor
143 HK022 kan (neo) cor
144 Phi80 kan (neo) cor
146 mEp234 kan (neo) cor
151 lambda+ cm (cat) bor
153 HK022 cm (cat) cor
154 Phi80 cm (cat) cor
160 lambda+ amp (bla) bor
Lysogens were then transformed with PCR products by electro-
poration. To enable a recombination event with the prophage,
lysogens carried the plasmid pKD46, a temperature-sensitive
low-copy number plasmid that expresses the λ Red genes under
the control of an arabinose-inducible promoter and were induced
with 20 mM arabinose prior to electroporation. Transformed cells
were subsequently plated on the respective antibiotic and suc-
cessful transformants were isolated, induced and the recombi-
neered phages were inserted into fresh WT cells.
DETERMINATION OF OPTIMAL ANTIBIOTIC
CONCENTRATIONS TO USE IN COMPETITION
EXPERIMENTS
We measured bacterial growth of each strain across an antibiotic
gradient to identify suitable antibiotic concentrations for the com-
petition assays and to determine whether prophage carriage alone
(without ARGs) had an effect on antibiotic resistance. Growth
assays were performed for each strain at 37°C in triplicates in
96-well plates containing 10 different antibiotic concentrations,
no-drug controls, and contamination controls (medium only). At
the beginning (t = 0) and after 20 h (t = 20), we measured opti-
cal density at 600 nm (OD600). We fitted a Hill-function to the
data (Regoes et al. 2004) of the change in optical density (ODt
= 20 – ODt = 0) as a function of antibiotic concentration and ex-
tracted different inhibitory concentrations (ICs), at which growth
relative to that observed for the same strain in the absence of
the antibiotic was reduced by 20% (IC20), 30% (IC30), and 50%
(IC50). We confirmed that the ARGs encoded on prophages con-
ferred antibiotic resistance to lysogens by observing much higher
ICs for ARG-carrying lysogens compared to the WT (Fig. S1).
In preliminary competition assays, we observed the extinction of
the WT at concentrations higher than IC50. We therefore per-
formed the main competition experiment at the following antibi-
otic concentrations: high (IC50 for the WT; Kan: 2.17 μg/ml,
Cm: 1.31 μg/ml, Amp: 4.41 μg/ml), intermediate (IC30 for the
WT; Kan: 1.55 μg/ml, Cm: 1.08 μg/ml, Amp: 3.52 μg/ml), and
low (IC20 for theWT; Kan: 0.565μg/m, Cm: 0.623μg/ml, Amp:
1.8 μg/ml).
COMPETITION ASSAYS
To determine the costs and benefits for bacteria of carrying
prophages we performed competition assays between each lyso-
gen (Table 1) and a phenotypically marked version of the WT.
This competing strain is susceptible to each phage and antibiotic,
and is labeled with a fluorescent yellow-super-fluorescent pro-
tein (SYFP) marker (Gullberg et al. 2014). For the eight lyso-
gens where the prophage encoded an ARG (Table 1), we as-
sayed each lysogen with and without the respective antibiotic at
each concentration. For each ARG-carrying lysogen, we also as-
sayed a corresponding ARG-free lysogen (Table 1; carrying the
same prophage but without an ARG) in the same conditions. We
tested each of these combinations of lysogen (n = 8), ARGs
(with/without) and antibiotic concentration (zero, low, interme-
diate, high) in the presence and absence of a compound that in-
duces the lytic cycle (mitomycin C, at a final concentration of
0.5 μg/ml). With five independent biological replicates of each
strain, each originating from a single colony, this gave 640 com-
petitions in total. We also accounted for the effect of the SYFP
marker carried by the WT, by measuring the fitness of the SYFP-
labeled WT relative to the unlabelled WT in each of the tested
environmental conditions. We then subtracted the difference in
relative fitness between both WT strains from the fitness of each
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lysogen relative to the YFP-labeled WT for each environmental
condition.
For each treatment group, five independent biological repli-
cates of each competing strain derived from five different
colonies were inoculated in 5 ml of LB and grown overnight
at 37°C in a shaking incubator (180 rpm). The following day
we determined the optical density of each overnight culture at
600 nm and adjusted the OD of each culture to the lowest mea-
sured OD, to obtain similar concentrations of bacteria per cul-
ture. Then, cultures of each lysogen were mixed 1:1 (v:v) with
the SYFP-labelled WT, diluted 1:1000 into the respective envi-
ronment (combination of antibiotic concentration and mitomycin
C) in a 96-well microplate to initiate each competition culture,
and incubated overnight at 37°C. At the start of each competition
and after 24 h, absolute cell densities of the two competing pop-
ulations were determined by flow cytometry (Novosampler Pro;
ACEA Biosciences Inc., San Diego CA), where fluorescent (WT)
and non-fluorescent cells (lysogens) were counted, similarly to
past work on costs and benefits of antibiotic resistance (Qi et al.
2016). Competitive fitness was estimated as selection rate con-
stant, r, calculated as the difference of the realized Malthusian
parameters between competing strains (Lenski et al. 1991):
r = ln(abundancet=24/abundancet=0)lysogen −
ln(abundancet=24/abundancet=0)wildtype
DETECTION OF PROPHAGE ACQUISITION BY THE
WILD TYPE
We plated the competing-cultures after 24 h onto non-selective
and selective agar-plates (supplemented with the respective an-
tibiotic) to determine the presence and frequency of newly
antibiotic-resistant WT clones (which could grow on antibiotic
plates and were distinguished from the competing strain by yel-
low fluorescence). We did this only for competition cultures in-
volving ARG-carrying lysogens. To determine whether newly
antibiotic-resistant colonies had acquired antibiotic resistance by
lysogenization (acquiring the prophage), all antibiotic-resistant
WT clones were subsequently checked for the presence of the
respective prophage using prophage-induction by mitomycin C.
This works by incubating 100 μl of bacterial culture with 0.5
μg/ml mitomycin C for 4 hours in a spectrophotometer, measur-
ing optical density periodically. If prophages have been acquired,
we expect the population to crash and eventually clear completely
due to prophage induction and lysis, which in these conditions
typically occurs after ∼1-2 h (Refardt 2011). The supernatant
of these mitomycin C-induced cultures was further spotted on
a lawn of susceptible E. coli K12 MG1655, to confirm the pres-
ence of free phages in the induced cultures (see also below in
section “Production of free phages”). We also used a second test
for evidence of prophage acquisition, by assaying resistance of
each putative new lysogen to a virulent mutant of the respective
prophage (prophage acquisition is expected to confer immunity
against superinfection by the same phage genotype). We did this
by cross-streaking each putative new lysogen over a line of the re-
spective lytic phage (Refardt 2011), and inferred resistance when
new lysogens showed no visible sign of inhibition by phage after
24 h incubation.
We estimated the relative fitness of the new lysogens (WT
clones that acquired antibiotic resistance via lysogenization dur-
ing the competition assay) by competition assays as above. We
did this for each new lysogen against the ancestral WT (telling
us about the net effect of acquiring the prophage including the
ARG), the ancestral lysogen without the respective ARG (telling
us about the effect of the ARG), and the ancestral lysogen with
the ARG (which we would expect to have similar fitness to the
new lysogens). Competitive fitness assays were performed in
triplicate in the absence of antibiotics and at the IC20 of the re-
spective antibiotic as above.
PRODUCTION OF FREE PHAGES
Lysogens can release free phages due to spontaneous prophage
induction or in response to environmental stress, such as ex-
posure to mitomycin C (Pricer and Weissbach 1964). In addi-
tion to the competition assays, we determined the production of
free phages for each tested lysogen in the same eight environ-
ments used during competition assays (four antibiotic concentra-
tions each tested in the presence and absence of mitomycin C)
by means of standard spot-assays (Carlson 2005) in a separate
experiment. Overnight cultures of each lysogen (with and with-
out ARGs), grown from single colonies, were diluted 1/1000 in
5 ml LB and incubated for 2 h to bring cultures into exponen-
tial growth. Each of these 2 h-growth cultures was adjusted to
a similar optical density (OD 600 nm) to achieve approximately
equal cell densities, before 180 μl was transferred to a 96-well
microplate. After 4 h (when induction had completed, which was
visible by complete clearance of mitomycin C-treated cultures),
we diluted each culture 1/10 in SM-Buffer, added a drop of chlo-
roform, and centrifuged for 10 min at 5000 × g to remove bac-
teria and isolate any free phages. To estimate the abundance of
free phages in each culture, we then spotted a dilution series of
these lysates on double-agar plates containing theWT in the over-
lay agar. Plates were incubated overnight at 37°C and plaque-
forming units (PFU) were counted the following day, with three
replicates per treatment.
REDUCTION IN BACTERIAL GROWTH CAUSED BY
FREE PHAGES
We measured the ability of free phages to inhibit population
growth of the WT by determining the reduction in bacterial
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growth (RBG) in liquid culture, adapted from (Poullain et al.
2008). To do this we first isolated free phages from each lysogen
(Table 1), by induction as described above using 0.5 μg/ml mito-
mycin C in the absence of antibiotics. We then incubated cultures
of the WT in 96-well plates, with each culture containing either
no antibiotics or one of the three antibiotics (ampicillin, chloram-
phenicol, or kanamycin) at IC20, IC30, or IC50. Each culture was
inoculated at a concentration of ×∼1.3 × 108 CFU/ml of bacte-
ria, to which we added ∼6.7×108 PFU/ml of one of the phages
or no phage (control). We then estimated bacterial abundance by
measuring optical density at 600 nm at t = 0 h and again at t = 24
h of static incubation at 37°C, with three replicates per treatment.
The reduction in bacterial growth was calculated as:
RBG = 1 − (OD600t=24 − OD600t=0)withphage/ (OD600t=24)
(−OD600t=0)withoutphage
STATISTICAL ANALYSES
All analyses were performed in R version 3.5.3.
Relative fitness
Our experimental design was not fully factorial (our strains repre-
sent a subset of all possible phage×ARG combinations; Table 1).
We, therefore, split the dataset by antibiotic, which allowed us to
fit a fully factorial linear model within each antibiotic treatment.
In a first model, we took lysogen fitness relative to the WT in the
absence of mitomycin C as the response variable, biological repli-
cate as a random effect, and as fixed effects, we included antibi-
otic concentration (zero, IC20, IC30, IC50), ARG (with/without),
and phage (Lambda, HK022, Phi80 or mEp234 for kanamycin;
Lambda, HK022 or Phi for chloramphenicol; phage not included
for ampicillin because only Lambda was represented with this an-
tibiotic; Table 1). In a second model, we included the treatment
groups with mitomycin C added, and mitomycin C (presence/ ab-
sence) as a fixed factor. In both models, we initially included all
interaction terms, before reducing each model by sequentially re-
moving non-significant interactions.
To separate the fitness effects of prophage carriage from
the fitness effects of ARGs, we estimated the average fitness ef-
fect of each prophage in each treatment group (combination of
antibiotic, antibiotic concentration, mitomycin C, and prophage
type) as the mean selection rate constant for the ARG-free lyso-
gen relative to the WT. We then estimated the average fitness
effect of each prophage-encoded ARG in each treatment group
as the difference in mean selection rate constant between each
ARG-carrying lysogen and the corresponding ARG-free lysogen
in the same treatment group. That is, the fitness effect of the
ARG here is the additional cost/benefit of the ARG in compe-
tition with a prophage-free strain, after accounting for any fitness
effect of the prophage the ARG is carried on (measured sepa-
rately with the equivalent ARG-free lysogen). Next, to determine
which treatment groups were associated with similar fitness ben-
efits of prophages and ARGs, we performed a pairwise-distance
cluster analysis robust to outliers. We clustered treatment groups
according to the variables (i) mean prophage fitness effect and (ii)
mean ARG fitness effect. We did this separately for each antibi-
otic. Preliminary analysis of within-cluster sums of squares for
different levels of k (the number of clusters) suggested that two
to five clusters gave good levels of explanatory power for each
antibiotic, so we proceeded with k-means clustering using km =
3 in the R package ComplexHeatmap.
Fitness costs of ARGs without antibiotics/mitomycin C
We tested for an average effect of ARGs on bacterial fitness in
the absence of antibiotics and mitomycin C using a pairwise t-test
comparing lysogens with versus without ARGs across all phage
and ARG combinations. To determine the smallest fitness effect
detectable with this test, we used power analysis with the function
power.t.test, with power = 0.8, p = 0.05, SD = 0.74 and n = 8.
This revealed that this test would detect significant fitness effects
greater than r = 0.85.
Production of free phages in each environmental
condition and absolute cell densities
Absolute cell densities during the pairwise competitions and free
phage production of each lysogen in the same conditions were
analyzed following the same approach as for relative fitness data,
using a log-transformation for free phage abundances (measured
in PFU/ml). We further performed a correlation analysis to deter-
mine whether the average relative fitness of lysogens in different
treatment groups was correlated with the amount of free phages
produced by lysogens in the same conditions (but measured in a
separate experiment).
Phage predation rate
We determined differences in RBG for the different phages for
each antibiotic using a linear model with antibiotic concentration,
presence/absence of the respective ARG, phage type, and all their
interactions as fixed effects, reducing the model as above.
Lysogenization
Using data on the fraction of competition assays where we ob-
served new lysogens, we used logistic regression to estimate
the probability for the WT population to acquire an ARG-
carrying prophage (lysogenization) in each environmental con-
dition (treatment group). We took presence/absence of new lyso-
gens in each competition culture as the dependent variable and
presence/absence of mitomycin C, antibiotic concentration (zero,
IC20, IC30, or IC50), and phage type as independent variables.
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We pooled the data from the different antibiotic treatments here,
because we found no effect of antibiotic (and therefore the type
of resistance gene) on the probability to acquire an ARG-carrying
prophage (glm: χ2(df = 2) = 0.7, p = 0.71). The full model was
analyzed by a generalized linear model and Analysis of Deviance,
for which we assumed deviance change to be approximately χ2
distributed.
Relative fitness of WT-lysogens
To analyse the fitness of new lysogens (WT colony isolates that
acquired an ARG-carrying prophage during the competition ex-
periment), we used a linear mixed effects model (package: nlme,
function lme) for each antibiotic (Amp, Cm, and Kan) with
prophage type, presence/absence of antibiotics (IC20), and com-
petitor (Phage-and-ARG-free WT, ARG-free lysogen, and ARG-
carrying lysogen) and their interactions as fixed effects, and lyso-
gen as a random effect.
Growth rate in monoculture
We used the SummarizeGrowth function implemented in the R
package growthcurver (Sprouffske and Wagner 2016) to estimate
the intrinsic growth rate for each strain (Table 1) in the absence of
antibiotics or mitomycin C.We usedWelch’s pairwise t-tests with
sequential Bonferroni correction to determine whether individual
lysogens had different growth rates compared to the WT.
Results
NET BENEFITS OF ARG-ENCODING PROPHAGES
INCREASE AT HIGHER ANTIBIOTIC
CONCENTRATIONS
In the absence of antibiotics and mitomycin C, prophage-carrying
strains (lysogens) generally had a competitive fitness greater than
or similar to the WT (selection rate constant ≥0; Fig. 1A). In
these conditions, we did not detect an average difference between
lysogens where the prophage encoded an ARG and those where
it did not (paired t-test: t7 = 0.45, p = 0.67; Fig. 1A). Note we
do not exclude costs of ARGs too small for our method to detect
(see Methods) or for individual lysogens, although in only three
out of eight cases estimated fitness was lower with the ARG than
without. Together, this suggests that in general, neither ARGs nor
prophages were costly in the absence of antibiotics. This was sup-
ported by experiments in monoculture, where we observed simi-
lar growth rates for lysogens compared to the WT (mean differ-
ence of lysogen growth rate from WT = 3.8% ±16.6% (s.d.);
Figure S2).
Upon addition of antibiotics (but without mitomycin C), av-
erage lysogen fitness increased (antibiotic concentration effect
in linear model for mitomycin C-free treatment groups - ampi-
cillin treatment group: F3,28 = 104.255, p < 0.001; chloram-
phenicol treatment group: F3,108 = 38.81, p < 0.001; kanamycin
treatment group: F3,148 = 6.36, p < 0.001; Fig. 1A). This ef-
fect was driven by lysogens with ARG-carrying prophages, in-
dicating resistance genes became advantageous at higher antibi-
otic concentrations (antibiotic concentration × ARG interaction
in linear model for mitomycin C-free treatment groups - ampi-
cillin: F3,28 = 18.03, p< 0.001, chloramphenicol: F3,108 = 25.58,
p < 0.001, kanamycin: F1,148 = 5.14, p = 0.002; Fig. 1A). By
contrast, only a minority of ARG-free lysogens showed notable
fitness increases, and only at certain antibiotic concentrations
(Fig. 1A). While the increasing advantage of ARGs was quali-
tatively consistent across all ARG-encoding prophages, the aver-
age fitness advantage of the ARG (relative to ARG-free versions
of the same prophages) was higher for chloramphenicol- and
ampicillin-resistance than for kanamycin-resistance (Fig. 1A).
BENEFITS OF ARGS AND PROPHAGES PEAK IN
DIFFERENT ENVIRONMENTAL CONDITIONS
For most lysogens addition of mitomycin C had a relatively
strong, positive effect on average lysogen fitness relative to the
WT at non-zero antibiotic concentrations (Fig. 1B). This was the
case for all lysogens in the kanamycin treatment group (mito-
mycin C × antibiotic concentration interaction for kanamycin
treatment group: F3, 250 = 114.56, p < 0.001; Fig. 1B) and for
some lysogens in the chloramphenicol treatment group (F3, 186 =
0.62, p = 0.6; significant only at antibiotic concentration = IC30:
Estimate = 2.88, t = 2.65, p = 0.009). In the ampicillin treatment
group, addition of mitomycin C did not result in higher average
lysogen fitness at non-zero concentrations (Fig. 1B), as it did in
the kanamycin-treatment lysogens.
The increasing benefits of ARGs at non-zero antibiotic con-
centrations observed in the absence of mitomycin C (Fig. 1A)
were modified by addition of mitomycin C (mitomycin C×ARG
× antibiotic concentration interaction for chloramphenicol: F3,186
= 8.71, p < 0.001; for kanamycin: F3,250 = 9.55, p < 0.001;
Fig. 1B). This was because in the absence of mitomycin C and
at non-zero antibiotic concentrations, carriage of an ARG had
a larger effect on lysogen fitness than carrying a prophage did
(in Cluster 3, there was a higher average benefit of ARGs than
prophages, and these treatment groups were mostly mitomycin
C-free; Fig. 1C). In contrast, in the presence of mitomycin C,
the fitness benefits of ARGs relative to prophages were less pro-
nounced or even absent, and lysogen fitness was primarily de-
termined by prophage carriage (in Cluster 1 there was a higher
benefit of prophages than ARGs, and mitomycin C was present
in most of these treatment groups; Fig. 1C). Crucially, this pattern
of relatively large benefits of prophage carriage in the presence of
mitomycin C, and of ARG carriage in the absence of mitomycin
C and presence of antibiotics, was consistent across all three
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Figure 1. Competitive fitness of lysogens relative to the antibiotic-susceptible and phage-susceptible Wild Type in the (A) absence and
(B) presence of mitomycin C. Each row of panels shows data from a different combination of antibiotic (given at right of panel C) and
prophage type (given at right of panel B). Shown are single data points as well as means ± s.e. from six replicate populations. Black/grey
points indicate lysogens without/with ARGs, assayed in competition with the WT at different antibiotic concentrations (x-axis). Lysogens
have higher fitness than theWTwhen the selection rate constant r> 0. (c) Benefits of ARGs (left column) and prophages (right column) in
different treatment groups (labeled at the right of the heatmap), clustered by k-means clustering (see Methods). Data have been scaled
using the scale function implemented in R prior to the cluster analysis.
antibiotics (Fig. 1C). The reduced benefit of ARG carriage was
particularly pronounced in the presence of ampicillin and mito-
mycin C, where AmpR-lysogens were at a disadvantage relative
to the WT (Fig, 1B and C).
We observed no significant variation of mean lysogen fit-
ness among the four different prophage types (lambda, HK022,
Phi80, mEp234) in the presence of kanamycin (prophage type
effect for kanamycin: F3, 250 = 1.59, p = 0.19). However, in
the presence of chloramphenicol, average lysogen fitness varied
among prophage types (prophage type effect for chlorampheni-
col: F2,186 = 40.88, p < 0.001; Fig. 1). This indicates the vari-
ation of lysogen fitness across different types of ARG-carrying




Figure 2. Production of free phages in the presence (grey) and absence (black) of mitomycin C. The number of cultures (y-axis) with
each amount of produced phages (x-axis) is shown for competition cultures involving ARG-free lysogens (left panel) and ARG-carrying
lysogens (right panel). Further details, including variation depending on all of the factors we tested and among replicates within each
treatment group, are shown in Figure S3.
INCREASED LYSOGEN FITNESS IN ENVIRONMENTAL
CONDITIONS THAT SUPPORT HIGHER FREE-PHAGE
PRODUCTION
When grown in monoculture, almost all lysogens produced free
phages in every experimental environment (except for prophage
lambda carrying the ampicillin resistance gene; Figure S3). Ad-
dition of mitomycin C significantly increased the average amount
of released phages (effect of mitomycin C: ampicillin treatment
group: F1,38 = 61.44, p < 0.001; chloramphenicol treatment
group: F1,107 = 25.84, p < 0.001; kanamycin treatment group:
F1,110 = 81.39, p < 0.001; Fig. 2). This indicates that, in the
competition experiments above, addition of mitomycin C was
probably also associated with increased free phage production.
Consistent with these treatments being associated with relatively
high lysogen fitness in the competition experiment, we observed
a positive association across all treatment groups between aver-
age lysogen fitness in the competition experiment and the con-
centration of free phages measured in monoculture (r = 0.2, p
= 0.02; Fig. S4). Note while free phage abundance was strongly
influenced by mitomycin C, it also varied depending on which
phages were present, being on average higher in cultures includ-
ing ARG-carrying lysogens (Fig. S3). Bacterial densities in those
cultures were relatively high compared to cultures with ARG-
free lysogens (linear model: F1,958 = 34.503, p < 0.001), which
potentially explains the increased total free phage production we
observed.
In the competition experiments, mitomycin C also caused
a significant reduction in total bacterial population densities, by
more than one order of magnitude compared to mitomycin C-
free treatments (mean ± SD = 8.48 × 107 ± 8.45 × 106 cells/ml
with versus 1.25 × 109 ± 7.23 × 107 cells/ml without; linear
model - ampicillin treatment group: t = −6.3, p < 0.001; chlo-
ramphenicol treatment group: t = −3.95, p < 0.001; kanamycin
treatment group: t = −2.03, p = 0.04; Fig. S5). This reduc-
tion in population density could have resulted from direct killing
or growth inhibition by mitomycin C (for both the lysogen
and the WT in each competition). Alternatively, it could have
resulted from the effects of prophage induction and lysis (of
prophage carrying cells upon switching to the lytic cycle, and
of WT cells by released free phages). We found growth of the
prophage-free WT was not strongly reduced by mitomycin C at
this concentration in pure culture (Fig. S6). Prophage-carrying
strains showed temporal growth dynamics upon exposure to mit-
omycin C in pure culture (Fig. S6) consistent with prophage
induction and abrupt lysis of a large fraction of the popula-
tion, rather than constant growth inhibition by mitomycin C in-
dependent of the prophage. This suggests the reduced popula-
tion densities in the presence of mitomycin C in competition
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Table 2. Treatment groups of all 16 populations where putative WT-lysogens (that appeared to have acquired a prophage during pair-
wise competition) were detected. We only looked at competition cultures involving ARG-carrying lysogens. Frequency: colony count for
new WT lysogens in each culture as a percentage of the total colony count for the WT population.
Phage genotype Mitomycin C Antibiotic Concentration Cluster Frequency (%)
Lambda Y amp IC50 1 0.06
Lambda Y amp IC30 1 0.06
Lambda Y amp IC30 1 0.08
Lambda Y cm IC30 1 0.06
Lambda Y cm IC30 1 0.16
Lambda Y cm IC30 1 0.05
Lambda Y cm IC20 1 0.09
Lambda Y cm IC20 1 0.08
Lambda Y cm IC20 1 0.04
Lambda Y cm IC50 2 0.37
Lambda Y kan IC50 1 0.04
Lambda Y kan IC30 1 0.04
Lambda Y kan IC30 1 6.67
HK022 N kan IC20 2 25
Phi80 Y kan IC30 1 15.38
mEp234 N kan 0 2 0.24
HK022 N cm IC30 3 0
cultures were probably caused by prophage induction, result-
ing in cell death of the induced lysogens and subsequent killing
of the competing WT population by released phages. In sup-
port, using reduction in bacterial growth (RBG) assays, we con-
firmed the wild type was highly susceptible to growth inhibi-
tion by free phages (Fig. S7). Thus, experimental conditions
supporting increased free phage production by lysogens were
associated with increased competitive fitness of lysogens rela-
tive to the WT, even though both strains reached lower absolute
abundances compared to when free phages were less abundant
(Fig. S5).
LIKELIHOOD OF ARG-TRANSFER BY PROPHAGES
VARIES WITH ENVIRONMENTAL CONDITIONS
In 16 out of 320 pairwise competitions involving ARG-carrying
lysogens, we detected putative new lysogens (descended from the
prophage-free WT strain) that appeared to have acquired ARG-
carrying prophages from the competing lysogen populations
(Table 2). Note, we carried out these additional experiments only
for competition cultures involving ARG-carrying lysogens. The
acquisition of ARG-carrying prophages was evidenced by the
WT strain becoming antibiotic resistant, becoming inducible by
mitomycin C (including the production of free phages that could
subsequently infect a susceptible WT clone), and becoming re-
sistant to a virulent mutant of the respective prophage (see Meth-
ods). 15 of these 16 WT lysogens emerged in the presence of
antibiotics (antibiotic concentration effect in logistic regression:
χ23 = 8.52, p = 0.04). Thirteen of the WT lysogens were de-
tected in the presence of mitomycin C (mitomycin C effect in
logistic regression: χ21 = 8.36, p = 0.004). The combination
of intermediate antibiotic concentrations (IC20 and IC30) and
the presence of mitomycin C were the same environmental con-
ditions where lysogen fitness peaked in the competition exper-
iments. These mostly fall into cluster one, representing envi-
ronmental conditions where prophage carriage was more bene-
ficial than ARG carriage (Fig. 1C). Finally, most new (WT) lyso-
gens emerged in cultures with lambda prophages (12 out of 16),
suggesting the probability of prophage-mediated ARG-transfer
to a susceptible strain differs across prophage types (effect of
prophage type in logistic regression: χ23 = 12.73, p = 0.005,
Table 2).
ACQUISITION OF ARG-CARRYING PROPHAGES
INCREASES BACTERIAL FITNESS IN THE PRESENCE
OF ANTIBIOTICS
To determine how acquisition of ARG-carrying prophages in
our main experiment affected bacterial fitness in these condi-
tions, we carried out pairwise competitions between the newWT-
lysogens (isolated from the competition experiment) and each of
three different ancestral strains: (1) phage-free-ARG-freeWT, (2)
ARG-free lysogens with the same type of prophage, (3) ARG-
carrying lysogens with the same type of prophage and ARG. We
found that the fitness of new WT-lysogens relative to compet-
ing bacteria was affected by increasing antibiotic concentration,
but this effect depended on the identity of the competing bacte-
ria (competitor × environment interaction: ampicillin treatment
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Figure 3. Competitive fitness of new WT-lysogens relative to each of three competing ancestral strains (left: in competition with the
phage-free, ARG-free Wild Type; middle: in competition with an ARG-free lysogen with the same prophage type; right: in competition
with an ARG-carrying lysogen with the same prophage type). Fitness was measured in the absence and presence of antibiotics (x-axis).
Different colors correspond to different ARGs (see legend). Each line gives the mean ± s.e. across all of the new-WT lysogens we isolated
for each ARG; individual reaction norms for every new WT-lysogen (each isolated from one of the 16 populations where we detected
new lysogens, Table 2) are given in Figure S8. New WT-lysogens have a higher fitness than the competing strain when r > 0.
group: F2,50 = 8.53, p< 0.001; chloramphenicol treatment group:
F2,157 = 134.99, p<0.001; kanamycin treatment group: F2,184 =
50.17, p<0.001; Fig. 3, and Figure S8). When they competed
with either WT bacteria or ARG-free lysogens (Fig. 3 left and
middle columns), new WT lysogens had a fitness advantage in
the presence but not the absence of antibiotics. By contrast, when
they competed with ARG-carrying lysogens (Fig. 3 right col-
umn), new WT lysogens had similar competitive fitness across
the two environmental conditions. Thus, new WT lysogens be-
haved similarly to the bacteria they acquired prophages from,
with a fitness advantage contingent on antibiotics and the pres-
ence of antibiotic-susceptible competitors.
Discussion
We found fitness benefits resulting from prophage carriage
peaked in different experimental environments compared to
fitness advantages of prophage-encoded adaptive genes (here
antibiotic resistance genes, ARGs). Prophage-encoded ARGs,
which were not associated with fitness costs in the absence of
antibiotics on average (Andersson and Levin 1999), were more
beneficial in environmental conditions where prophage induc-
tion was less frequent but antibiotics were present (cluster 3 in
Fig. 1C). In contrast, prophages were more beneficial than ARGs
in environmental conditions where induction of the lytic cycle
was more frequent (cluster 1 in Fig. 1C). This beneficial ef-
fect of prophage carriage is likely driven by the release of free
phages which, as determined in a separate experiment, was great-
est in treatment groups where lysogen fitness was highest. Upon
prophage induction, we expect the released phage particles infect
and lyse competing, phage-susceptible WT cells (as observed in
pure cultures - Figure S7; for a detailed review see (Harrison and
Brockhurst 2017)). By selectively killing phage susceptible com-
petitors, prophages can therefore increase the competitive fitness
of their hosts (Bossi et al. 2003; Brown et al. 2006; De Paepe
et al. 2016; Haaber et al. 2016). However, this benefit was (1)
only visible at the population level, as individual cells are pre-
sumably killed upon induction of the lytic cycle (Fig. S5) and (2)
depended on being surrounded by competitors susceptible to the
released phages, as lysogens did not grow better than prophage-
free strains in monoculture without antibiotics and mitomycin C
(Figure S2). We observed formation of new WT lysogens in a
small fraction of populations, indicating released phages can also
drive genetic exchange.
The competitive advantage of lysogens over prophage-free
competitors we observed supports the notion of a mutualistic,
rather than parasitic, relationship between prophages and bacteria
(Bondy-Denomy and Davidson 2014; Nanda et al. 2015; Fillol-
Salom et al. 2019). In our experiments, the benefits of prophages
appeared to result not only from their carriage of ARGs, but the
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release of free phages that then lysed competing bacteria. Such
killing of phage-susceptible competitors has been observed in
other systems, where the release of free phages indirectly ben-
efits their carriers during the bacterial competition (Selva et al.
2009; Burns et al. 2015; Li et al. 2017) and facilitates microbial
invasion (Brown et al. 2006). Released phages can also integrate
into the chromosomes of competing bacteria, as observed in our
new WT lysogens. In this case, the competitor becomes resistant
to the phage and the beneficial effect of the phage to its original
host population disappears. One way to overcome this resistance
evolution is polylysogeny (carriage of more than one prophage)
in some bacteria (Burns et al. 2015). In this case, when the com-
petitor becomes resistant to one of the released phages, other re-
leased phages might still be able to kill the competitor. Thus, the
prevalence of prophages in bacterial genomes may reflect a com-
bination of direct competitive benefits in some environments and
their role in the exchange of genetic material (Jain et al. 1999;
Ochman et al. 2000; Koonin et al. 2001). Indeed, prophages can
constitute up to 20% of bacterial genomes and contribute signif-
icantly to sequence diversity among isolates (Casjens 2003). For
instance, pathogenic E. coli serogroup O157 contains between
15 and 18 different prophages, which account for most of the in-
creased genome size (5.5 Mb) compared to K-12 MG1655 (4.6
Mb, (Perna et al. 2001)).
An important implication of our results is that we found only
a few experimental conditions where both ARGs and prophages
were beneficial (left and right panels both red in Fig. 1C). In other
words, in most environmental conditions it was advantageous for
bacteria to have a prophage, an ARG, or neither, but not both a
prophage and an ARG. This is consistent with, and helps to ex-
plain, metagenomic evidence that prophages rarely encode ARGs
(Enault et al. 2017). An interesting avenue for future research
would be to look for comparative evidence of whether bacterial
strains with ARGs and prophages at separate loci gain similar fit-
ness benefits compared to those with ARG-encoding prophages.
One limitation of our study is that we used engineered lyso-
gens instead of naturally isolated lysogens. However, this ap-
proach enabled us to disentangle the effects of prophages and
ARGs, and to show that this applied across multiple phage types
and antibiotics. Despite this, we observed variation of lysogen
fitness across phage types in our chloramphenicol treatment, and
a cost of prophage carriage for lambda lysogens in the presence
of ampicillin and mitomycin C. This suggests lysogen fitness is
also influenced by an interaction between the type of prophage
and the type of antibiotic. There are multiple possible mecha-
nisms by which such an interaction could arise, and an inter-
esting avenue for future work would be to investigate this for
a much larger range of prophage types and antibiotics, includ-
ing multiple antibiotics from each class. We nevertheless spec-
ulate that the relatively high fitness of prophage-free bacteria in
the presence of ampicillin may reflect the mechanism of ampi-
cillin resistance. For β-lactams such as ampicillin, resistance is
often mediated via β-lactamases that deactivate the antibiotic, re-
ducing the effective concentration and potentially diminishing in-
hibitory effects on susceptible cells in mixed cultures (Medaney
et al. 2016). We also note that we performed our experiments in
plain LB, without additional magnesium and calcium ions that
would promote phage adsorption. Infection and lysis/lysogeny of
susceptible cells might therefore be even more effective in condi-
tions supporting higher adsorption rates per bacterium-virus en-
counter.
Some key properties of our experimental conditions are nev-
ertheless likely to also apply in nature. Many pathogenic E. coli
harbor lambdoid prophages (Casjens 2003), and co-occurrence of
closely related enterobacteria that differ in their prophage reper-
toire are common in gastrointestinal tracts. Moreover, in animal
farms, sub-MIC concentrations of antibiotics are likely common
as a result of antibiotic application as growth promoters and pro-
phylactics (Van Boeckel et al. 2015). Thus, we can expect condi-
tions that would favor bacterial acquisition of such ARG-carrying
prophages to be widespread. Understanding the drivers of lyso-
gen fitness, such as variable free phage production depending
on abiotic conditions as we observed, is therefore important for
predicting the risk that prophage-encoded ARGs could spread
from agricultural or natural environments to human microbiota
or pathogens.
Another key implication of our results is that lysogenization
of phage-susceptible cells by ARG-carrying prophages appears
to be most likely in the presence of antibiotics and in conditions
where free phage abundance is high. There are at least two pos-
sible explanations. First, the relatively high benefits of acquiring
prophages and ARGs in these conditions presumably increased
their final abundance and the probability of us detecting them.
For ARGs, we observed stronger fitness benefits in the presence
of antibiotics, both in our main competition assay and in experi-
ments with newWT lysogens. Independently of ARGs, the bene-
fits of prophage acquisition were higher in the presence of mito-
mycin C and antibiotics. This may result from the relatively high
abundances of free phages in these treatment groups, indicated by
our phage-production experiment. In such conditions, we can ex-
pect the benefits of prophage acquisition stemming from immu-
nity to super-infection (Lwoff 1953; van Houte et al. 2016) to be
relatively high. Consistent with this, previous work showed that
prophages can enhance lysogen competitiveness by lysing phage-
susceptible competitors (Gama et al. 2013; Davies et al. 2016).
Note that, as well as mitomycin C, other antibiotics or drugs can
induce the lytic cycle and trigger the release of free phages. Even
though we did not observe prophage induction upon exposure to
any of the three antibiotics used in the present study, this has been
observed for instance for prophages of E. coli O157:H7 (Zhang
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et al. 2000), Staphylococcus aureus (Ubeda et al. 2005; Maiques
et al. 2006) and the virus-like gene transfer agent VSH-1 in the
swine pathogen Brachyspira hyodysenteriae (Matson et al. 2005;
Stanton et al. 2008). We therefore speculate that in other systems,
exposure to antibacterial compounds can promote new lysogens,
either via direct selection for prophage-encoded resistance genes
or indirectly by enhancing free phage production, which in turn
selects for prophage-derived resistance to superinfection.
A second, non-exclusive explanation for the bias of new
lysogen formation toward antibiotic- and mitomycin C treat-
ments is that the frequency of lysogenization events of competing
cells per phage-bacteria contact may be higher in these treatment
groups. Lysogeny is controlled by both, the phage and the host
(Herskowitz and Hagen 1980). For instance, if bacteria are grow-
ing in sub-optimal/stressful conditions, such as low temperatures
(Obuchowski et al. 1997) or under starvation, lambda is biased
toward the lysogenic over the lytic cycle (Herskowitz and Ha-
gen 1980). Similarly, when the multiplicity of infection (MOI) is
high, lysogeny is favored (Kourilsky 1973; Kobiler et al. 2005).
We observed trends consistent with these results. Lysogeniza-
tion of the phage-susceptible WT population was favored under
those environmental conditions that resulted in a high number
of free infecting phage particles and at sub-inhibitory antibiotic
concentrations.
Conclusions
We provide empirical evidence that the benefits to lysogens of
carrying prophages and adaptive genes encoded thereon vary in-
dependently across environmental conditions. Prophages have
fitness benefits independent of any ARGs they carry, which are
probably driven by the release of free phages that lyse compet-
ing phage-susceptible cells, and consequently, vary with envi-
ronmental factors affecting induction of the lytic cycle. Disen-
tangling the benefits of prophages and ARGs improves our un-
derstanding of selection on prophages in the presence of phage-
susceptible competitors (Gama et al. 2013; Davies et al. 2016).
More generally, our results provide new information about the
evolutionary biology of mobile genetic elements, by showing that
selection on MGEs themselves and adaptive genes they carry
can vary independently across environmental conditions. This
helps to explain the mixed evidence of whether prophages fre-
quently encode ARGs. Finally, we found the horizontal trans-
fer of phage-encoded resistance genes to phage- and antibiotic
susceptible strains were relatively common for certain prophage
types and at non-zero (but sub-MIC) concentrations of antibi-
otics. This improves our understanding of the conditions in which
ARG-encoding phages are likely to spread, both vertically and
horizontally, in bacterial communities.
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Table S1. Primer sequences that were used to amplify resistance cassettes and exchange them with non-essential genes in prophages.
Figure S1. Bacterial growth measured at multiple concentrations of three antibiotics (given in panel labels at top).
Figure S2. Growth rate [r] of each lysogen in the absence of antibiotics and mitomycin C, arranged by prophage type (x-axis) and antibiotic resistance
gene (see legend).
Figure S3. Free phage abundance in pure cultures of lysogens in the absence (left column) and presence (right column) of mitomycin C at different
antibiotic concentrations (x-axis).
Figure S4. Correlation between log-transformed free phage abundance (measured after four hours in pure cultures of lysogens; y-axis) and lysogen
relative fitness (measured in competition with the prophage-free WT; x-axis).
Figure S5. Bacterial population densities in competitions between (a) ARG-free lysogens and Wild Type bacteria and (b) ARG-carrying lysogens and
Wild Type bacteria.
Figure S6. Population density of each strain over time (20 h) in the presence of mitomycin C (0.5 μg/ml).
Figure S7. Reduction in bacterial growth (1-RBG) imposed by free phages for each phage genotype (columns, labelled at top) for each antibiotic (rows,
labelled at right), without an ARG = black, with ARG = grey at four antibiotic concentrations (x-axis).
Figure S8. Competitive fitness of new WT-lysogens relative to each of three competing ancestral strains (left: phage-free, ARG-free Wild Type; middle:
ARG-free lysogen with the same prophage type; right: ARG-carrying lysogen with the same prophage type), in the absence and presence of antibiotics
(x-axis).
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